Impact of initial body mass index (BMI) on survival outcome of patients with acute leukemia (AL): myth or reality?
Maël Heiblig(Université Claude Bernard Lyon 1), Xavier Thomas(Hôpital Lyon Sud), Nicolini Franck-emmanuel(Hôpital Lyon Sud), Fiorenza Barraco(Hôpital Lyon Sud), Mohamed El Hamri(Hospices Civils de Lyon), Mauricette Michallet(Université Claude Bernard Lyon 1), Eric Wattel(Université Claude Bernard Lyon 1), Sophie Ducastelle-Leprêtre(Hospices Civils de Lyon), Hélène Labussière(Hôpital Lyon Sud), Véronique Lhéritier(Hospices Civils de Lyon)
Cited by 0
Related Papers
Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study
|The Lancet|2012|1k
Should Adolescents With Acute Lymphoblastic Leukemia Be Treated as Old Children or Young Adults? Comparison of the French FRALLE-93 and LALA-94 Trials
|Journal of Clinical Oncology|2003|606
p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies
|Blood|1994|581
Pediatric-Inspired Therapy in Adults With Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia: The GRAALL-2003 Study
|Journal of Clinical Oncology|2009|562
Outcome of Treatment in Adults With Acute Lymphoblastic Leukemia: Analysis of the LALA-94 Trial
|Journal of Clinical Oncology|2004|547